7.03
-0.05(-0.71%)
Currency In USD
| Previous Close | 7.08 |
| Open | 7.07 |
| Day High | 7.22 |
| Day Low | 6.95 |
| 52-Week High | 17.43 |
| 52-Week Low | 5.6 |
| Volume | 1.85M |
| Average Volume | 3.03M |
| Market Cap | 553.89M |
| PE | 3.18 |
| EPS | 2.21 |
| Moving Average 50 Days | 9.49 |
| Moving Average 200 Days | 11.29 |
| Change | -0.05 |
If you invested $1000 in CorMedix Inc. (CRMD) 10 years ago, it would be worth $736.13 as of February 21, 2026 at a share price of $7.03. Whereas If you bought $1000 worth of CorMedix Inc. (CRMD) shares 5 years ago, it would be worth $410.63 as of February 21, 2026 at a share price of $7.03.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
CorMedix Therapeutics Announces Share Repurchase Program
GlobeNewswire Inc.
Feb 02, 2026 1:30 PM GMT
BERKELEY HEIGHTS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced
CorMedix Therapeutics to Host In-Person and Virtual Analyst Day in New York on February 10, 2026
GlobeNewswire Inc.
Jan 29, 2026 1:30 PM GMT
BERKELEY HEIGHTS, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 09, 2026 1:30 PM GMT
BERKELEY HEIGHTS, N.J., Jan. 09, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced